Loading clinical trials...
Loading clinical trials...
Browse 1,498 clinical trials for liver disease. Find studies that match your criteria and connect with research centers.
Find trials near:
Showing 1161-1180 of 1,498 trials
NCT00965900
This study is performed to compare the efficacy and safety of EBL, propranolol, and EBL combined with propranolol in patients with medium or large varices.
NCT03172650
Non-alcoholic fatty liver disease is the most common cause of chronic liver disease worldwide. It is defined as the accumulation of fat (\>5%) in the liver cells in the absence of excessive alcohol intake or other causes of liver disease including viral, drug-induced, or autoimmune. Non-alcoholic fatty liver disease is a hepatic manifestation of metabolic syndrome.